BOSTON SCIENTIFIC CORP financial data

Symbol
BSX on NYSE
Location
Marlborough, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 149% % 3.3%
Quick Ratio 55% % 17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,483,885,456 shares 0.55%
Entity Public Float $158,700,000,000 USD 40%
Common Stock, Value, Issued $17,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 1,480,400,000 shares 0.6%
Weighted Average Number of Shares Outstanding, Diluted 1,494,500,000 shares 0.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $20,074,000,000 USD 20%
Operating Income (Loss) $3,613,000,000 USD 39%
Nonoperating Income (Expense) $311,000,000 USD -9.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,385,000,000 USD 48%
Income Tax Expense (Benefit) $493,000,000 USD 13%
Earnings Per Share, Basic 1.96 USD/shares 56%
Earnings Per Share, Diluted 1.94 USD/shares 55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,965,000,000 USD 375%
Inventory, Net $2,943,000,000 USD 4.7%
Other Assets, Current $701,000,000 USD 4%
Assets, Current $8,794,000,000 USD 27%
Deferred Income Tax Assets, Net $3,675,000,000 USD 0.55%
Property, Plant and Equipment, Net $4,036,000,000 USD 23%
Operating Lease, Right-of-Use Asset $465,000,000 USD 3.6%
Intangible Assets, Net (Excluding Goodwill) $7,019,000,000 USD 5%
Goodwill $18,282,000,000 USD 7%
Other Assets, Noncurrent $1,866,000,000 USD 6.4%
Assets $43,673,000,000 USD 11%
Accounts Payable, Current $1,144,000,000 USD 19%
Employee-related Liabilities, Current $1,426,000,000 USD 11%
Accrued Liabilities, Current $3,201,000,000 USD 15%
Liabilities, Current $5,439,000,000 USD -15%
Long-term Debt and Lease Obligation $11,137,000,000 USD 24%
Accrued Income Taxes, Noncurrent $403,000,000 USD 11%
Deferred Income Tax Liabilities, Net $220,000,000 USD 42%
Operating Lease, Liability, Noncurrent $446,000,000 USD 11%
Other Liabilities, Noncurrent $2,405,000,000 USD 29%
Accumulated Other Comprehensive Income (Loss), Net of Tax $610,000,000 USD -322%
Retained Earnings (Accumulated Deficit) $5,571,000,000 USD 108%
Stockholders' Equity Attributable to Parent $24,233,000,000 USD 11%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $24,472,000,000 USD 11%
Liabilities and Equity $43,673,000,000 USD 11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $541,000,000 USD 230%
Net Cash Provided by (Used in) Financing Activities $233,000,000 USD -85%
Net Cash Provided by (Used in) Investing Activities $500,000,000 USD -75%
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 1,746,290,165 shares 0.49%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $314,000,000 USD -78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,147,000,000 USD 254%
Deferred Tax Assets, Valuation Allowance $1,202,000,000 USD -5.2%
Deferred Tax Assets, Gross $4,857,000,000 USD -2.7%
Operating Lease, Liability $536,000,000 USD 11%
Depreciation $471,000,000 USD 14%
Payments to Acquire Property, Plant, and Equipment $187,000,000 USD 4.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,013,000,000 USD -3.2%
Lessee, Operating Lease, Liability, to be Paid $656,000,000 USD 16%
Property, Plant and Equipment, Gross $7,645,000,000 USD 12%
Operating Lease, Liability, Current $90,000,000 USD 11%
Operating Lease, Weighted Average Discount Rate, Percent 0.041 pure 5.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $121,000,000 USD 48%
Deferred Tax Assets, Operating Loss Carryforwards $626,000,000 USD -19%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $596,000,000 USD 18%
Amortization of Intangible Assets $897,000,000 USD 4.8%
Depreciation, Depletion and Amortization $325,000,000 USD 6.9%
Deferred Tax Assets, Net of Valuation Allowance $3,655,000,000 USD -1.8%
Interest Expense $349,000,000 USD 14%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%